Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotinamide Riboside in Diabetic Polyneuropathy

NCT03685253 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03685253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotinamide Riboside in Diabetic Polyneuropathy
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 1/2
Overall status
Terminated
Start date
January 24, 2019
Completion date
May 1, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy peripheral